Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

Scipher Medicine, Galapagos Sign IBD Drug Development Deal

The companies will jointly validate novel drug targets identified by Scipher's molecular interaction network platform for patients with inflammatory bowel disease.

Mission Bio Raises $70M in Series C Funding Round

The South San Francisco-based firm will use the funding to scale its Tapestri single-cell multi-omics technology to pharma trials and for characterization for cell and gene therapies.

Broad Institute, One Mind Win $518K Grant for Alzheimer's Disease Research

Broad and One Mind scientists will use single-cell RNA sequencing technologies to investigate the role of microglia in Alzheimer's disease onset and progression.

Caris Life Sciences, Elevation Oncology Partner on Patient Enrollment for Tumor-Agnostic Drug Trial

Caris will use its suite of technologies to help Elevation Oncology enroll patients with NRG1 fusion-positive solid tumors to its Phase II trial of seribantumab.

Singapore's Avatamed Raises $1M in Seed Funding

Avatamed will use the funds to expand into the Asia-Pacific market and set up a lab in Singapore to provide precision cancer drug screening services.

Aug 06, 2020

GeneCentric, Erasmus University to Research RNA Biomarkers, Therapies for Bladder Cancer

Aug 03, 2020

Metabolon, Merck KGaA Form Metabolomics Alliance

Jul 27, 2020

Centogene, Molecular Health Sign Collaboration to Improve Orphan Drug Development

Jul 24, 2020

Curi Bio Acquires Artificial Intelligence Firm Dana Solutions

Jul 22, 2020

Ultivue, OracleBio Collaborate on Tissue Biomarker Analysis Workflow

Jul 15, 2020

ReviveMed, Bristol Myers Squibb to Study Metabolomics for Cancer Immunotherapy

Jul 14, 2020

Merus, Caris Life Sciences Partner to ID NRG1 Fusion-Positive Cancer Patients for Clinical Trial

Jul 08, 2020

Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases

Jul 01, 2020

Celsius Therapeutics Teams With Oxford, Cleveland Clinic, LMU on Single-Cell IBD Research

Jun 24, 2020

Cyclica Raises C$23M in Series B Round

Jun 23, 2020

Illumina Adds Seven International Startups to Business Accelerator Program

Jun 18, 2020

FDA Approves Epizyme's Tazverik, Roche CDx for EZH2-Mutated Follicular Lymphoma Patients

Jun 18, 2020

Israeli Startup Curesponse Targets European Pharma Market With Drug Prediction, Development Service

Premium

Jun 10, 2020

10x Genomics, MilliporeSigma Collaborate on CRISPR Screening Workflow

Jun 02, 2020

10x Genomics, Collaborators Develop Targeted Single-Cell Gene Expression Methods

Premium

May 21, 2020

Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

Premium

May 20, 2020

Omics-Driven Drug Discovery Firm Octant Raises $30M in Series A Financing Round

May 13, 2020

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19

Premium

May 07, 2020

Twist Bioscience Q2 Revenues Increase 42 Percent

Apr 30, 2020

Mount Sinai Researchers Mine Literature, Social Media for COVID-19 Gene and Drug Resource

Premium

The Scan

This One Might Not Be Due to Humans

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Not the Wings

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

More Vaccines on Order

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

Science Studies Include Ion Channel Mutation Prediction Model, Variant Linked to Disrupted Sleep

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

CAS-CLOVER The clean alternative to CRISPR/Cas9 for gene editing in the drug discovery and development industry

Aug

24

Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Aug

27

Featured Webinar

CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

Over 70 percent of breast cancers are estrogen receptor positive and are treated with endocrine therapy.

Sep

09

Featured Webinar

Spatially Resolved Transcriptomics: The Landscape of Tools for Spatial Gene Expression

Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems.

Sep

10

Featured Webinar

Development of RNA-Based Predictive Response Signatures as Companion Diagnostics

This webinar, Part 2 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will focus on the development of RNA-based companion diagnostics for oncology.

Menu

Drug Discovery & Development

What's Popular?